Methods and formulations for converting intravenous and...

Details Methods and formulations for converting intravenous and... Methods and formulations for converting intravenous and...

A - Human Necessities

61

K

A61K 9/16 (2006.01) A61K 9/107 (2006.01) A61K 9/127 (2006.01) A61K 31/337 (2006.01) A61K 38/13 (2006.01)

Patent

CA 2701023

Oral dosage compositions for drugs normally given intravenously such as Paclitaxel, containing a plant sterol to enhance solubility and a small intestine efflux inhibitor to prevent P-glycoprotein from being a barrier to absorption.

L'invention concerne des compositions de dosage orales pour des médicaments normalement administrés par voie intraveineuse comme du Paclitaxel, contenant un stérol végétal pour améliorer la solubilité et un inhibiteur d'écoulement de l'intestin grêle pour empêcher la P-glycoprotéine d'être une barrière à l'absorption.

Affiliated with

Also associated with

Rating

Methods and formulations for converting intravenous and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and formulations for converting intravenous and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and formulations for converting intravenous and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1352635